sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC)
GPTKB entity
Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alternativeName |
SNAC
|
| gptkbp:chemicalFormula |
C16H22NNaO4
|
| gptkbp:discoveredBy |
gptkb:Emisphere_Technologies
|
| gptkbp:mechanismOfAction |
enhances transcellular absorption of peptides
increases local pH in stomach protects peptides from enzymatic degradation |
| gptkbp:usedAs |
oral drug absorption enhancer
|
| gptkbp:usedFor |
gptkb:insulin
gptkb:semaglutide |
| gptkbp:usedIn |
oral semaglutide formulation
|
| gptkbp:bfsParent |
gptkb:oral_semaglutide
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
sodium N-(8-[2-hydroxybenzoyl]amino)caprylate (SNAC)
|